Afuco™ Anti-Human FGB ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FGB ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an anti-fibrin chimeric antibody that reacts with fibrin only, and not fibrinogen, and then attached an anticancer agent (ACA) to the antibody. Thus, the immunoconjugate did not create an immune complex in the blood stream and was selectively accumulated to fibrin clots in the tumor stroma to create a scaffold, from which effective sustained release of the ACA occurred. This new cancer stroma-targeting therapy may result in an increased duration of drug exposure and be a highly effective new therapy, particularly for refractory, stroma-rich cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-264CL |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | FGB |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |